Immune polarization by hookworms: Taking cues from T helper type 2, type 2 innate lymphoid cells and alternatively activated macrophages

Immunology

Volumn 148, Issue 2, 2016, Pages 115-124

  Nair, Meera G ^a   Herbert, De'Broski R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Helminth infection; Helminth therapy; Innate lymphoid cell; M2 macrophage; T helper type 2

Indexed keywords

ANTHELMINTIC AGENT; CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 22; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 9; MUCIN 2; MUCIN 5AC; OKT 4; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; STAT6 PROTEIN; T LYMPHOCYTE RECEPTOR; PARASITE ANTIGEN;

ANCYLOSTOMA DUODENALE; ANTIGEN SPECIFICITY; ARTICLE; BEAR; DRUG TARGETING; HELMINTHIASIS; HOOKWORM; HOOKWORM INFECTION; HUMAN; IMMUNE RESPONSE; LYMPHOID CELL; MACROPHAGE; MACROPHAGE ACTIVATION; NECATOR AMERICANUS; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PARASITE IMMUNITY; PARASITISM; POPULATION; PRIORITY JOURNAL; SPECIES DIVERSITY; TH2 CELL; THERAPY WITH HELMINTHS; ANCYLOSTOMA; ANCYLOSTOMIASIS; ANIMAL; CELL DIFFERENTIATION; COMPLEMENT ALTERNATIVE PATHWAY; IMMUNOLOGY; INNATE IMMUNITY; NECATORIASIS; NIPPOSTRONGYLUS; PARASITOLOGY; STRONGYLE INFECTION;

ANCYLOSTOMA; ANCYLOSTOMIASIS; ANIMALS; ANTIGENS, HELMINTH; CELL DIFFERENTIATION; COMPLEMENT PATHWAY, ALTERNATIVE; HUMANS; IMMUNITY, INNATE; MACROPHAGE ACTIVATION; MACROPHAGES; NECATOR AMERICANUS; NECATORIASIS; NIPPOSTRONGYLUS; STRONGYLIDA INFECTIONS; TH2 CELLS;

EID: 84962636700     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12601     Document Type: Article

References (89)

1. Prevention, C. f. D. C. a. 2013. Global health - division of parasitic diseases and malaria.
2. Loukas A, Prociv P. Immune responses in hookworm infections. Clin Microbiol Rev 2001; 14:689-703. table of contents.
3. Matthys B, Tschannen AB, Tian-Bi NT, Comoe H, Diabate S, Traore M, et al. Risk factors for Schistosoma mansoni and hookworm in urban farming communities in western Cote d'Ivoire. Trop Med Int Health 2007; 12:709-23.
4. Hawdon JM, Hotez PJ. Hookworm: developmental biology of the infectious process. Curr Opin Genet Dev 1996; 6:618-23.
5. Hotez PJ, Bundy DAP, Beegle K, Brooker S, Drake L, de Silva N, et al. Chapter 24: Helminth Infections: soil-transmitted Helminth Infections and Schistosomiasis. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, eds. Disease Control Priorities in Developing Countries, 2nd edn. Washington (DC): World Bank, 2006.
6. Kalsheker NA, Deam S, Chambers L, Sreedharan S, Brocklehurst K, Lomas DA. The house dust mite allergen Der p1 catalytically inactivates alpha 1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma. Biochem Biophys Res Commun 1996; 221:59-61.
7. Jelinek T, Maiwald H, Nothdurft HD, Loscher T. Cutaneous larva migrans in travelers: synopsis of histories, symptoms, and treatment of 98 patients. Clin Infect Dis 1994; 19:1062-6.
8. Reece JJ, Siracusa MC, Southard TL, Brayton CF, Urban JF Jr, Scott AL. Hookworm-induced persistent changes to the immunological environment of the lung. Infect Immun 2008; 76:3511-24.
9. Craig JM, Scott AL. Helminths in the lungs. Parasite Immunol 2014; 36:463-74.
10. Siracusa MC, Kim BS, Spergel JM, Artis D. 2013. Basophils and allergic inflammation. J Allergy Clin Immunol 132: 789-801. quiz 788.
11. Ramalingam TR, Pesce JT, Sheikh F, Cheever AW, Mentink-Kane MM, Wilson MS, et al. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chain. Nat Immunol 2008; 9:25-33.
12. Behnke JM. Do hookworms elicit protective immunity in man? Parasitology today 1987; 3:200-6.
13. Greenwald RJ, Latchman YE, Sharpe AH. Negative co-receptors on lymphocytes. Curr Opin Immunol 2002; 14:391-6.
14. Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 2010; 236:219-42.
15. Urban JF Jr, Maliszewski CR, Madden KB, Katona IM, Finkelman FD. IL-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice. J Immunol 1995; 154:4675-84.
16. Urban JF Jr, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, et al. IL-13, IL-4Rα, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998; 8:255-64.
17. + T cells in the IgE response and immunity to Nippostrongylus brasiliensis. J Immunol 1988; 140:3206-11.
18. Quinnell RJ, Pritchard DI, Raiko A, Brown AP, Shaw MA. Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. J Infect Dis 2004; 190:430-8.
19. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, et al. Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9:1341-6.
20. Roncarolo MG, Gregori S, Bacchetta R, Battaglia M. Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol 2014; 380:39-68.
21. Anthony RM, Rutitzky LI, Urban JF Jr, Stadecker MJ, Gause WC. Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007; 7:975-87.
22. Harvie M, Camberis M, Tang SC, Delahunt B, Paul W, Le Gros G. The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites. Infect Immun 2010; 78:3753-62.
23. Logan E, Chetty A, Horsnell WG. The role of antibody in parasitic helminth infections. Adv Exp Med Biol 2014; 828:1-26.
24. Herbst T, Esser J, Prati M, Kulagin M, Stettler R, Zaiss MM, et al. Antibodies and IL-3 support helminth-induced basophil expansion. Proc Natl Acad Sci USA 2012; 109:14954-9.
25. Horsnell WG, Darby MG, Hoving JC, Nieuwenhuizen N, McSorley HJ, Ndlovu H, et al. IL-4Rα-associated antigen processing by B cells promotes immunity in Nippostrongylus brasiliensis infection. PLoS Pathog 2013; 9:e1003662.
26. Ohnmacht C, Schwartz C, Panzer M, Schiedewitz I, Naumann R, Voehringer D. Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 2010; 33:364-74.
27. Urban JF Jr, Noben-Trauth N, Schopf L, Madden KB, Finkelman FD. Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites. J Immunol 2001; 167:6078-81.
28. Hasnain SZ, Evans CM, Roy M, Gallagher AL, Kindrachuk KN, Barron L, et al. Muc5ac: a critical component mediating the rejection of enteric nematodes. J Exp Med 2011; 208:893-900.
29. + T cell production of IFN-γ and infection-induced intestinal inflammation. J Immunol 2008; 181:4709-15.
30. Cliffe LJ, Humphreys NE, Lane TE, Potten CS, Booth C, Grencis RK. Accelerated intestinal epithelial cell turnover: a new mechanism of parasite expulsion. Science 2005; 308:1463-5.
31. Madden KB, Yeung KA, Zhao A, Gause WC, Finkelman FD, Katona IM, et al. Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal epithelial cell function. J Immunol 2004; 172:5616-21.
32. Finkelman FD, Shea-Donohue T, Morris SC, Gildea L, Strait R, Madden KB, et al. Interleukin-4- and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol Rev 2004; 201:139-55.
33. Zhao A, McDermott J, Urban JF Jr, Gause W, Madden KB, Yeung KA, et al. Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J Immunol 2003; 171:948-54.
34. Hasnain SZ, Wang H, Ghia JE, Haq N, Deng Y, Velcich A, et al. Mucin gene deficiency in mice impairs host resistance to an enteric parasitic infection. Gastroenterology 2010; 138:1763-71.
35. Horsnell WG, Vira A, Kirstein F, Mearns H, Hoving JC, Cutler AJ, et al. IL-4Rα-responsive smooth muscle cells contribute to initiation of TH2 immunity and pulmonary pathology in Nippostrongylus brasiliensis infections. Mucosal Immunol 2011; 4:83-92.
36. Shea-Donohue T, Sun R, Bohl JA, McLean LP, Zhao A. Enteric nematodes and the path to up-regulation of type 2 cytokines IL-4 and IL-13. Cytokine 2015; 75:62-7.
37. Barnes MA, Carson MJ, Nair MG. Non-traditional cytokines: how catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine 2015; 72:210-9.
38. + dermal dendritic cells and drive protective cutaneous immunity. Immunity 2015; 43:515-26.
39. Seidl A, Panzer M, Voehringer D. Protective immunity against the gastrointestinal nematode Nippostrongylus brasiliensis requires a broad T-cell receptor repertoire. Immunology 2011; 134:214-23.
40. Guo L, Huang Y, Chen X, Hu-Li J, Urban JF Jr, Paul WE. Innate immunological function of TH2 cells in vivo. Nat Immunol 2015; 16:1051-9.
41. Oeser K, Schwartz C, Voehringer D. Conditional IL-4/IL-13-deficient mice reveal a critical role of innate immune cells for protective immunity against gastrointestinal helminths. Mucosal Immunol 2015; 8:672-82.
42. Schmidt S, Hoving JC, Horsnell WG, Mearns H, Cutler AJ, Brombacher TM, et al. Nippostrongylus-induced intestinal hypercontractility requires IL-4 receptor α-responsiveness by T cells in mice. PLoS ONE 2012; 7:e52211.
43. Cheever AW, Williams ME, Wynn TA, Finkelman FD, Seder RA, Cox TM, et al. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 1994; 153:753-9.
44. Kullberg MC, Berzofsky JA, Jankovic DL, Barbieri S, Williams ME, Perlmann P, et al. T cell-derived IL-3 induces the production of IL-4 by non-B, non-T cells to amplify the Th2-cytokine response to a non-parasite antigen in Schistosoma mansoni-infected mice. J Immunol 1996; 156:1482-9.
45. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells-how did we miss them? Nature reviews. Immunology 2013; 13:75-87.
46. + lymphoid cells. Nature 2010; 463:540-4.
47. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464:1367-70.
48. H 2 cytokine responses. Nature 2010; 464:1362-6.
49. Fallon PG, Smith P, Richardson EJ, Jones FJ, Faulkner HC, Van Snick J, et al. Expression of interleukin-9 leads to Th2 cytokine-dominated responses and fatal enteropathy in mice with chronic Schistosoma mansoni infections. Infect Immun 2000; 68:6005-11.
50. Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 2013; 210:2951-65.
51. Halim TY, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG, et al. Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol 2016; 17:57-64.
52. + T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014; 41:283-95.
53. Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun 2015; 6:6970.
54. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176:287-92.
55. Doyle AG, Herbein G, Montaner LJ, Minty AJ, Caput D, Ferrara P, et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur J Immunol 1994; 24:1441-5.
56. Du L, Wei H, Li L, Shan H, Yu Y, Wang Y, et al. Regulation of recombinant Trichinella spiralis 53-kDa protein (rTsP53) on alternatively activated macrophages via STAT6 but not IL-4Rα in vitro. Cell Immunol 2014; 288:1-7.
57. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004; 20:623-35.
58. Van Dyken SJ, Locksley RM. Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 2013; 31:317-43.
59. Odegaard JI, Chawla A. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nat Clin Pract Endocrinol Metab 2008; 4:619-26.
60. Odegaard JI, Ricardo-Gonzalez RR, Red Eagle A, Vats D, Morel CR, Goforth MH, et al. Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance. Cell Metab 2008; 7:496-507.
61. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 2007; 447:1116-20.
62. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-69.
63. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999; 189:1363-72.
64. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 2009; 5:e1000371.
65. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD, et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 2014; 123:e110-22.
66. Loke P, Allison JP. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proc Natl Acad Sci USA 2003; 100:5336-41.
67. Borthwick LA, Barron L, Hart KM, Vannella KM, Thompson RW, Oland S, et al. Macrophages are critical to the maintenance of IL-13-dependent lung inflammation and fibrosis. Mucosal Immunol 2016; 9:38-55.
68. H 2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med 2012; 18:260-6.
69. Chen F, Wu W, Millman A, Craft JF, Chen E, Patel N, et al. Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion. Nat Immunol 2014; 15:938-46.
70. Zhao A, Urban JF Jr, Anthony RM, Sun R, Stiltz J, van Rooijen N, et al. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 2008; 135(217-225):e211.
71. O'Neill LA, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med 2016; 213:15-23.
72. Huang SC, Everts B, Ivanova Y, O'Sullivan D, Nascimento M, Smith AM, et al. Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol 2014; 15:846-55.
73. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332:243-7.
74. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 2010; 11:936-44.
75. H 2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 2006; 12:955-60.
76. Obata-Ninomiya K, Ishiwata K, Tsutsui H, Nei Y, Yoshikawa S, Kawano Y, et al. The skin is an important bulwark of acquired immunity against intestinal helminths. J Exp Med 2013; 210:2583-95.
77. Pesce JT, Ramalingam TR, Wilson MS, Mentink-Kane MM, Thompson RW, Cheever AW, et al. Retnla (relmα/fizz1) suppresses helminth-induced Th2-type immunity. PLoS Pathog 2009; 5:e1000393.
78. Jang JC, Chen G, Wang SH, Barnes MA, Chung JI, Camberis M, et al. Macrophage-derived human resistin is induced in multiple helminth infections and promotes inflammatory monocytes and increased parasite burden. PLoS Pathog 2015; 11:e1004579.
79. Sutherland TE, Logan N, Ruckerl D, Humbles AA, Allan SM, Papayannopoulos V, et al. Chitinase-like proteins promote IL-17-mediated neutrophilia in a tradeoff between nematode killing and host damage. Nat Immunol 2014; 15:1116-25.
80. Yazdanbakhsh M, Kremsner PG, van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002; 296:490-4.
81. Leonardi-Bee J, Pritchard D, Britton J. Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am J Respir Crit Care Med 2006; 174:514-23.
82. Flohr C, Tuyen LN, Quinnell RJ, Lewis S, Minh TT, Campbell J, et al. Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam. Clin Exp Allergy 2010; 40:131-42.
83. Gaze S, Bethony JM, Periago MV. Immunology of experimental and natural human hookworm infection. Parasite Immunol 2014; 36:358-66.
84. Maxwell C, Hussain R, Nutman TB, Poindexter RW, Little MD, Schad GA, et al. The clinical and immunologic responses of normal human volunteers to low dose hookworm (Necator americanus) infection. Am J Trop Med Hyg 1987; 37:126-34.
85. Mortimer K, Brown A, Feary J, Jagger C, Lewis S, Antoniak M, et al. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am J Trop Med Hyg 2006; 75:914-20.
86. Feary JR, Venn AJ, Mortimer K, Brown AP, Hooi D, Falcone FH, et al. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy 2010; 40:299-306.
87. Croese J, Giacomin P, Navarro S, Clouston A, McCann L, Dougall A, et al. Experimental hookworm infection and gluten microchallenge promote tolerance in celiac disease. J Allergy Clin Immunol 2015; 135:508-16.
88. Chiu IM, Heesters BA, Ghasemlou N, Von Hehn CA, Zhao F, Tran J, et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature 2013; 501:52-7.
89. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011; 480:104-8.